Jecure
discovers and develops small-molecule therapeutics for the treatment of non-alcoholic steatohepatitis and liver fibrosis... Read moreJecure
discovers and develops small-molecule therapeutics for the treatment of non-alcoholic steatohepatitis and liver fibrosis... Read more
2016
PrivateSubsidiary of Genentech, Inc.
News
Nov 28, 2018
BioPortfolio
Jecure: Roche enters NASH race with deal to buy Jecure
Nov 27, 2018
FinSMEs
Jecure Therapeutics: Genentech Acquires Jecure Therapeutics
Jan 19, 2018
BioSpace
Jecure Therapeutics: What You Need to Know About Jecure Therapeutics
Dec 18, 2017
Biospectrum Asia
Jecure Therapeutics: Jecure Therapeutics announces the appointment of Vice President for its Biology division
Dec 14, 2017
PharmiWeb
Jecure Therapeutics: Jecure Therapeutics Strengthens Management Team
Feb 20, 2017
Drug Discovery & Development
Jecure Therapeutics: Versant Ventures Launches Jecure Therapeutics
Feb 16, 2017
PharmaLeaders
Jecure Therapeutics: Versant Ventures launches biotechnology firm Jecure Therapeutics
Feb 15, 2017
socalTECH
Jecure Therapeutics: Jecure Therapeutics Raises $20M From Versant Ventures
Feb 14, 2017
BioCentury
Jecure Therapeutics: NASH play Jecure raises $20M in debut
Feb 14, 2017
http://www.fiercebiotech.com
Jecure Therapeutics: Versant's Jecure Therapeutics debuts with a focus on NASH, fibrosis
Jecure Competitors
1
2
3
4
5
6
7
8
9
10